ERTUGLIFLOZIN PIDOLATE\SITAGLIPTIN: 89 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
89
Total FAERS Reports
3 (3.4%)
Deaths Reported
28
Hospitalizations
89
As Primary/Secondary Suspect
5
Life-Threatening
1
Disabilities
Active Ingredient: ERTUGLIFLOZIN PIDOLATE\SITAGLIPTIN PHOSPHATE ·
First Report: 20180611 · Latest Report: 20240713
What Are the Most Common ERTUGLIFLOZIN PIDOLATE\SITAGLIPTIN Side Effects?
#1 Most Reported
Vomiting
13 reports (14.6%)
#2 Most Reported
Gastrointestinal haemorrhage
12 reports (13.5%)
#3 Most Reported
Covid-19 pneumonia
12 reports (13.5%)
All ERTUGLIFLOZIN PIDOLATE\SITAGLIPTIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Vomiting | 13 | 14.6% | 0 | 13 |
| Covid-19 | 12 | 13.5% | 0 | 12 |
| Covid-19 pneumonia | 12 | 13.5% | 0 | 12 |
| Gastrointestinal haemorrhage | 12 | 13.5% | 0 | 12 |
| Product dose omission issue | 9 | 10.1% | 0 | 0 |
| Blood glucose increased | 7 | 7.9% | 0 | 1 |
| No adverse event | 6 | 6.7% | 0 | 0 |
| Ketoacidosis | 5 | 5.6% | 0 | 4 |
| Rash | 5 | 5.6% | 0 | 0 |
Who Reports ERTUGLIFLOZIN PIDOLATE\SITAGLIPTIN Side Effects? Age & Gender Data
Gender: 35.2% female, 64.8% male. Average age: 59.4 years. Most reports from: US. View detailed demographics →
Is ERTUGLIFLOZIN PIDOLATE\SITAGLIPTIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 4 | 0 | 1 |
| 2019 | 14 | 2 | 5 |
| 2020 | 11 | 0 | 0 |
| 2021 | 6 | 0 | 1 |
| 2023 | 18 | 0 | 15 |
| 2024 | 1 | 0 | 0 |
What Is ERTUGLIFLOZIN PIDOLATE\SITAGLIPTIN Used For?
| Indication | Reports |
|---|---|
| Type 2 diabetes mellitus | 27 |
| Diabetes mellitus | 21 |
| Product used for unknown indication | 12 |
Official FDA Label for ERTUGLIFLOZIN PIDOLATE\SITAGLIPTIN
Official prescribing information from the FDA-approved drug label.